CBX3在脑胶质瘤中的表达分析及其对胶质瘤细胞凋亡的抑制作用

doi:10.13418/j.issn.1001-165x.2022.5.11

中国临床解剖学杂志 ›› 2022, Vol. 40 ›› Issue (5): 562-568.doi: 10.13418/j.issn.1001-165x.2022.5.11

CBX3在脑胶质瘤中的表达分析及其对胶质瘤细胞凋亡的抑制作用

李炽阳，杨帆，杨悦，陆云涛，周强*

南方医科大学南方医院神经外科，广州 510000

收稿日期:2022-02-26 出版日期:2022-09-25 发布日期:2022-10-12
通讯作者: 周强，主治医师，博士，E-mail: ellisonchou@163.com
作者简介:李炽阳（1997-），男，安徽阜阳人，博士，主要从事脑胶质瘤治疗及耐药方面的机制研究，E-mail:947804460@qq.com
基金资助:
国家自然科学基金(81802830，81902887，81972355)；广东省自然科学基金（2019B151502048）

The expression of CBX3 in brain glioma and its influence on the apoptosis of glioma cell

Li Chiyang, Yang Fan, Yang Yue, Lu Yuntao, Zhou Qiang*

Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

Received:2022-02-26 Online:2022-09-25 Published:2022-10-12

摘要/Abstract

摘要： 目的通过对胶质瘤公共数据库中CBX3表达量的分析，明确其与胶质瘤预后的相关性。流式细胞术以及对凋亡指标的检测分析其对胶质瘤细胞系凋亡水平的影响。方法通过对TCGA以及CGGA中胶质瘤患者基因芯片的数据进行分析，比较CBX3在不同级别胶质瘤中的表达量以及分析CBX3表达量与胶质瘤患者预后之间的关系。GO和Pathway分析对CBX3基因进行功能注释。最后在细胞系中探索CBX3基因对胶质瘤细胞系凋亡水平的影响。结果高级别胶质瘤中CBX3表达量明显高于低级别的胶质瘤中CBX3的表达量(P<0.01) 。高表达CBX3的患者预后比低表达CBX3的患者更差( P<0.05)。同时流式细胞术实验发现过表达CBX3可以显著降低胶质母细胞瘤细胞系U87MG和T98G的凋亡水平。结论 CBX3的表达水平与胶质瘤的生存期呈负相关关系，高表达 CBX3可以降低胶质母细胞瘤细胞系的凋亡水平，故而CBX3或许可作为判断胶质母细胞瘤预后的有效指标。

关键词: 胶质母细胞瘤； , , CBX3； , , 生物信息学； , , 预后

Abstract: Objective To clarify the correlation between CBX3 and the prognosis of glioma by analyzing the expression of CBX3 in the glioma public database. Flow cytometry and the detection of apoptosis indexes were used to analyze its effect on the apoptosis level of glioma cell lines. Methods By analyzing the data of glioma patients gene chip in TCGA and CGGA, the expression of CBX3 in different grades of glioma was compared and the relationship between CBX3 expression and prognosis of glioma patients was analyzed. Functional annotation of the CBX3 gene by GO and Pathway analysis. Finally, the effect of CBX3 gene on the apoptosis level of glioma cell lines was explored in cell lines. Results The expression of CBX3 in high-grade gliomas was significantly higher than that in low-grade gliomas (P<0.01). The prognosis of patients with high CBX3 expression was worse than that of patients with low CBX3 expression (P<0.05). At the same time, flow cytometry experiments showed that overexpression of CBX3 could significantly reduce the apoptosis level of glioblastoma cell lines U87MG and T98G. Conclusion The expression level of CBX3 is negatively correlated with the survival time of glioma. High expression of CBX3 can reduce the apoptosis level of glioblastoma cell lines, so CBX3 may be an effective indicator for judging the prognosis of glioblastoma.

Key words: Glioblastoma; , , CBX3; , , Bioinformatics analysis; , , Prognosis

中图分类号:

R730.264

李炽阳, 杨帆, 杨悦, 陆云涛, 周强. CBX3在脑胶质瘤中的表达分析及其对胶质瘤细胞凋亡的抑制作用[J]. 中国临床解剖学杂志, 2022, 40(5): 562-568.

Li Chiyang, Yang Fan, Yang Yue, Lu Yuntao, Zhou Qiang. The expression of CBX3 in brain glioma and its influence on the apoptosis of glioma cell[J]. Chinese Journal of Clinical Anatomy, 2022, 40(5): 562-568.

参考文献 14

[1]	Zhou Q, Li JJ, Wang H, et al. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling[J].Carcinogenesis，2018，39(2):214-224. DOI:10.1093/carcin/bgx125.
[2]	Xu S, Tang L, Li X ,et al. Immunotherapy for glioma: Current management and future application[J].Cancer Lett，2020，476:1-12. DOI: 10.1016/j.canlet.2020.02.002.
[3]	Zhang N, Zhang H, Wang ZY, et al. Immune infiltrating cells-derived risk signature based on large-scale analysis defines immune landscape and predicts immunotherapy responses in glioma tumor microenvironment[J]. Front Immunol, 2021,12:691811. DOI: 10.3389/fimmu.2021.691811.
[4]	Yue X, Lan FM, Xia TY, Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt/β-catenin signaling and promotes radiation resistance by targeting TCEAL7[J]. Mol Ther, 2019, 27(11):1939-1949. DOI: 10.1016/j.ymthe.2019.07.011.
[5]	Zhong X, Kan A,Zhang W, et al.CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma[J]. Aging (Albany NY), 2019, 11(15):5483-5497. DOI: 10.18632/aging.102132.
[6]	Miller AM, Shah RH, Pentsova EI, et al. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid[J]. Nature, 2019, 565(7741):654-658. DOI: 10.1038/s41586-019-0882-3.
[7]	Lin H, Lian J, Xia L, et al. CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses[J].Cancer Manag Res, 2020,12:10113-10125. DOI: 10.2147/CMAR.S271807.
[8]	Zhao SP, Wang F, Yang M, et al. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis[J].J Neurooncol, 2019,145(1):35-48. DOI: 10.1007/s11060-019-03286-w.
[9]	吴亚辉，王韬甫，林洪启，基于JAK2/STAT3信号通路观察右美托咪定减轻大鼠心肌缺血再灌注损伤和抑制凋亡作用机制[J]. 中国临床解剖学杂志, 2022, 40(1): 55-61. DOI:10.13418/j.issn.1001-165x. 2022.1.11.
[10]	Smallwood A, Hon GC, Jin F, et al. CBX3 regulates efficient RNA processing genome-wide[J]. Genome Res, 2012, 22(8):1426-36. DOI: 10.1101/gr.124818.111.
[11]	Zhang H, Chen W, Fu X, et al. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma[J].Gene, 2018, 654:49-56. DOI: 10.1016/j.gene.2018.02.043.
[12]	Ruan J, Ouyang H, Amaya MF, et al. Structural basis of the chromodomain of Cbx3 bound to methylated peptides from histone h1 and G9a[J].PLoS One, 2012, 7(4):e35376. DOI: 10.1371/journal.pone.0035376.
[13]	Zaidan NZ, Sridharan R. HP1γ regulates H3K36 methylation and pluripotency in embryonic stem cells[J].Nucleic Acids Res, 2020, 48(22):12660-12674. DOI: 10.1093/nar/gkaa1091.
[14]	D'Angelo F, Ceccarelli M, Tala, et al.The molecular landscape of glioma in patients with Neurofibromatosis 1[J].Nat Med, 2019, 25(1):176-187. DOI: 10.1038/s41591-018-0263-8.

[1]	江剑宏, 段仁鹏, 李晓锋. 国人胆道三维重建解剖变异应用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 1-4.
[2]	郭红志, 王瑜, 张加琪, 梁海彬, 马梓玮, 冯伟, 吴忧, 司子燚. 血管铸型结合CT三维模型评估先兆子痫胎盘血管结构[J]. 中国临床解剖学杂志, 2024, 42(1): 5-10.
[3]	李佳伟, 张静, 李灿然, 兰文杰, 籍庆余, 郭志勇, 张云凤, 刘启, 陈清威, 李筱贺. 蒙古族人群股骨近端解剖参数X线测量[J]. 中国临床解剖学杂志, 2024, 42(1): 11-16.
[4]	李琨, 张燕, 郭冉, 郝咪咪, 吴轩宇, 徐艺芳, 王超群, 马文童, 张灵淇, 杨宏宇, 李志军, 张少杰, 王星. 儿童及青少年枕颈角与后枕颈角数字化测量及其临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 17-20.
[5]	李文, 杨思艺, 黄蕾, 卿霁雯, 蒋松涛, 张磊. 基于MRI探讨Lisfranc韧带的形态学特点及临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 21-25.
[6]	李凡凡, 徐阳, 王晓旭. 紫草素调节Nrf2/HO-1信号通路对实验性大鼠肉芽肿性小叶性乳腺炎的治疗作用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 26-32.
[7]	王兴航, 丁佳媛, 李放, 包翠芬, 阎丽菁. 人参皂苷Rg1通过抑制NLRP3炎症小体途径减轻氧糖剥夺/复供后小胶质细胞炎症反应[J]. 中国临床解剖学杂志, 2024, 42(1): 33-41.
[8]	程莹莹, 武建军, 蔡海燕, 焦旭文, 马江波, 丁银秀. 体外炎性诱导星形胶质细胞激活及功能分析[J]. 中国临床解剖学杂志, 2024, 42(1): 42-46.
[9]	祁志, 杨力, 贾秋叶, 陈浩伦, 段兆达, 吴春云. 依达拉奉经MAPKs通路对脂多糖激活的小胶质细胞Sirt3表达调控[J]. 中国临床解剖学杂志, 2024, 42(1): 47-53.
[10]	张晶晶, 王洪新. 黄芩苷通过PDGF/P38 MAPK信号通路对肺动脉高压大鼠的保护作用[J]. 中国临床解剖学杂志, 2024, 42(1): 54-58.
[11]	乐钦, 陈荣丽, 熊婧熙, 王婷怡, 蔡志恒, 易秋实, 曾心怡. 白芨多糖对大鼠跨区皮瓣choke区的影响[J]. 中国临床解剖学杂志, 2024, 42(1): 59-64.
[12]	李笑予, 张磊, 付磊, 李东波, 汪国友. 三步接骨法治疗Sanders Ⅱ型跟骨骨折的有限元研究[J]. 中国临床解剖学杂志, 2024, 42(1): 65-70.
[13]	吴研飞, 马剑雄, 卢斌, 王颖, 柏豪豪, 靳洪震, 马信龙. CT后处理技术重建CT值与终板抗压强度的相关性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 71-76.
[14]	庄万强, 唐毅, 骆勇刚, 张辉. 关节镜联合胫骨高位截骨术对髌骨位置及髌股关节功能影响的早中期回顾性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 77-82.
[15]	罗鹰, 窦伟誉, 吴小杭, 陈璟昆, 彭昌贵, 潘剑英 . 微创海马钢板内固定治疗跟骨骨折并发症的影响因素[J]. 中国临床解剖学杂志, 2024, 42(1): 83-88.

CBX3在脑胶质瘤中的表达分析及其对胶质瘤细胞凋亡的抑制作用

The expression of CBX3 in brain glioma and its influence on the apoptosis of glioma cell

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 14

相关文章 15

Metrics

本文评价

推荐阅读 0